Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Prediction intervals for penalized longitudinal models with multisource summary measures: An application to childhood malnutrition.

McLain AC, Frongillo EA, Feng J, Borghi E.

Stat Med. 2018 Nov 14. doi: 10.1002/sim.8024. [Epub ahead of print]

PMID:
30430613
2.

Up-Regulation of Antimicrobial Peptides Gallerimycin and Galiomicin in Galleria mellonella Infected with Candida Yeasts Displaying Different Virulence Traits.

Dekkerová-Chupáčová J, Borghi E, Morace G, Bujdáková H.

Mycopathologia. 2018 Dec;183(6):935-940. doi: 10.1007/s11046-018-0300-7. Epub 2018 Nov 1.

PMID:
30386966
3.

Antenatal Microbial Colonization of Mammalian Gut.

Borghi E, Massa V, Severgnini M, Fazio G, Avagliano L, Menegola E, Bulfamante GP, Morace G, Borgo F.

Reprod Sci. 2018 Oct 11:1933719118804411. doi: 10.1177/1933719118804411. [Epub ahead of print]

PMID:
30309297
4.

Prevalence thresholds for wasting, overweight and stunting in children under 5 years.

de Onis M, Borghi E, Arimond M, Webb P, Croft T, Saha K, De-Regil LM, Thuita F, Heidkamp R, Krasevec J, Hayashi C, Flores-Ayala R.

Public Health Nutr. 2019 Jan;22(1):175-179. doi: 10.1017/S1368980018002434. Epub 2018 Oct 9.

PMID:
30296964
5.

Treatment of male rats with finasteride, an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota composition.

Diviccaro S, Giatti S, Borgo F, Barcella M, Borghi E, Trejo JL, Garcia-Segura LM, Melcangi RC.

Psychoneuroendocrinology. 2019 Jan;99:206-215. doi: 10.1016/j.psyneuen.2018.09.021. Epub 2018 Sep 18.

PMID:
30265917
6.

The narrative interview in therapeutic education. The diabetic patients' point of view.

Picchi S, Bonapitacola C, Borghi E, Cassanelli S, Ferrari P, Iemmi B, Alfieri E, Artioli G.

Acta Biomed. 2018 Jul 18;89(6-S):43-50. doi: 10.23750/abm.v89i6-S.7488.

PMID:
30038203
7.

Phenylketonuric diet negatively impacts on butyrate production.

Verduci E, Moretti F, Bassanini G, Banderali G, Rovelli V, Casiraghi MC, Morace G, Borgo F, Borghi E.

Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):385-392. doi: 10.1016/j.numecd.2018.01.004. Epub 2018 Jan 31.

PMID:
29502926
8.

Body Mass Index and Sex Affect Diverse Microbial Niches within the Gut.

Borgo F, Garbossa S, Riva A, Severgnini M, Luigiano C, Benetti A, Pontiroli AE, Morace G, Borghi E.

Front Microbiol. 2018 Feb 14;9:213. doi: 10.3389/fmicb.2018.00213. eCollection 2018.

9.

Anti-biofilm activity of antibody directed against surface antigen complement receptor 3-related protein-comparison of Candida albicans and Candida dubliniensis.

Chupácová J, Borghi E, Morace G, Los A, Bujdáková H.

Pathog Dis. 2018 Feb 1;76(1). doi: 10.1093/femspd/ftx127.

PMID:
29315379
10.

Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality.

Soldini S, Posteraro B, Vella A, De Carolis E, Borghi E, Falleni M, Losito AR, Maiuro G, Trecarichi EM, Sanguinetti M, Tumbarello M.

Clin Microbiol Infect. 2018 Jul;24(7):771-777. doi: 10.1016/j.cmi.2017.11.005. Epub 2017 Nov 10.

PMID:
29133157
11.

Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests.

Borgo F, Riva A, Benetti A, Casiraghi MC, Bertelli S, Garbossa S, Anselmetti S, Scarone S, Pontiroli AE, Morace G, Borghi E.

PLoS One. 2017 Jun 21;12(6):e0179739. doi: 10.1371/journal.pone.0179739. eCollection 2017.

12.

Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.

Papp-Wallace KM, Becka SA, Zeiser ET, Ohuchi N, Mojica MF, Gatta JA, Falleni M, Tosi D, Borghi E, Winkler ML, Wilson BM, LiPuma JJ, Nukaga M, Bonomo RA.

ACS Infect Dis. 2017 Jul 14;3(7):502-511. doi: 10.1021/acsinfecdis.7b00020. Epub 2017 Mar 30.

13.

Rett Syndrome: A Focus on Gut Microbiota.

Borghi E, Borgo F, Severgnini M, Savini MN, Casiraghi MC, Vignoli A.

Int J Mol Sci. 2017 Feb 7;18(2). pii: E344. doi: 10.3390/ijms18020344.

14.

A rare case of subcutaneous fusariosis in an immunocompetent patient.

Mapelli ET, Cerri A, Borghi E, Palvarini M, Abramo P, Morace G, Menni S.

G Ital Dermatol Venereol. 2017 Apr;152(2):178-180. doi: 10.23736/S0392-0488.16.04787-8.

PMID:
28166614
15.

First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas.

Bonvalot S, Le Pechoux C, De Baere T, Kantor G, Buy X, Stoeckle E, Terrier P, Sargos P, Coindre JM, Lassau N, Ait Sarkouh R, Dimitriu M, Borghi E, Levy L, Deutsch E, Soria JC.

Clin Cancer Res. 2017 Feb 15;23(4):908-917. doi: 10.1158/1078-0432.CCR-16-1297. Epub 2016 Oct 6.

16.

A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents.

Polonelli L, Ciociola T, Elviri L, Zanello PP, Giovati L, Arruda DC, Muñoz JE, Mortara RA, Morace G, Borghi E, Galati S, Marin O, Casoli C, Pilotti E, Ronzi P, Travassos LR, Magliani W, Conti S.

Sci Rep. 2016 Oct 11;6:35018. doi: 10.1038/srep35018.

17.

Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations.

Riva A, Borgo F, Lassandro C, Verduci E, Morace G, Borghi E, Berry D.

Environ Microbiol. 2017 Jan;19(1):95-105. doi: 10.1111/1462-2920.13463. Epub 2016 Aug 22.

18.

Fungal Biofilms: Update on Resistance.

Borghi E, Borgo F, Morace G.

Adv Exp Med Biol. 2016;931:37-47. doi: 10.1007/5584_2016_7. Review.

PMID:
27115411
19.

Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy.

Tincati C, Merlini E, Braidotti P, Ancona G, Savi F, Tosi D, Borghi E, Callegari ML, Mangiavillano B, Barassi A, Bulfamante G, d'Arminio Monforte A, Romagnoli S, Chomont N, Marchetti G.

AIDS. 2016 Apr 24;30(7):991-1003. doi: 10.1097/QAD.0000000000001015.

PMID:
27028142
20.

Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study.

Borgo F, Verduci E, Riva A, Lassandro C, Riva E, Morace G, Borghi E.

Child Obes. 2017 Feb;13(1):78-84. doi: 10.1089/chi.2015.0194. Epub 2016 Mar 23.

PMID:
27007700
21.

Acute Scedosporium apiospermum Endobronchial Infection in Cystic Fibrosis.

Padoan R, Poli P, Colombrita D, Borghi E, Timpano S, Berlucchi M.

Pediatr Infect Dis J. 2016 Jun;35(6):701-2. doi: 10.1097/INF.0000000000001130.

PMID:
26967814
22.

Inhibition of ceramide de novo synthesis by myriocin produces the double effect of reducing pathological inflammation and exerting antifungal activity against A. fumigatus airways infection.

Caretti A, Torelli R, Perdoni F, Falleni M, Tosi D, Zulueta A, Casas J, Sanguinetti M, Ghidoni R, Borghi E, Signorelli P.

Biochim Biophys Acta. 2016 Jun;1860(6):1089-97. doi: 10.1016/j.bbagen.2016.02.014. Epub 2016 Feb 24.

PMID:
26922830
23.

Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007-2014.

Lovero G, Borghi E, Balbino S, Cirasola D, De Giglio O, Perdoni F, Caggiano G, Morace G, Montagna MT.

PLoS One. 2016 Feb 26;11(2):e0150218. doi: 10.1371/journal.pone.0150218. eCollection 2016.

24.

Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm.

Perdoni F, Signorelli P, Cirasola D, Caretti A, Galimberti V, Biggiogera M, Gasco P, Musicanti C, Morace G, Borghi E.

BMC Microbiol. 2015 Oct 30;15:248. doi: 10.1186/s12866-015-0588-0.

25.

New strategic insights into managing fungal biofilms.

Borghi E, Morace G, Borgo F, Rajendran R, Sherry L, Nile C, Ramage G.

Front Microbiol. 2015 Oct 6;6:1077. doi: 10.3389/fmicb.2015.01077. eCollection 2015.

26.

Successive 1-Month Weight Increments in Infancy Can Be Used to Screen for Faltering Linear Growth.

Onyango AW, Borghi E, de Onis M, Frongillo EA, Victora CG, Dewey KG, Lartey A, Bhandari N, Baerug A, Garza C; WHO Multicentre Growth Reference Study Group.

J Nutr. 2015 Dec;145(12):2725-31. doi: 10.3945/jn.115.211896. Epub 2015 Oct 14.

PMID:
26468489
27.

Metals as radio-enhancers in oncology: The industry perspective.

Pottier A, Borghi E, Levy L.

Biochem Biophys Res Commun. 2015 Dec 18;468(3):471-5. doi: 10.1016/j.bbrc.2015.09.027. Epub 2015 Sep 8. Review.

PMID:
26362175
28.

Docosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link?

Lassandro C, Banderali G, Radaelli G, Borghi E, Moretti F, Verduci E.

Int J Mol Sci. 2015 Aug 21;16(8):19989-20000. doi: 10.3390/ijms160819989. Review.

29.

The future of nanosized radiation enhancers.

Pottier A, Borghi E, Levy L.

Br J Radiol. 2015 Oct;88(1054):20150171. doi: 10.1259/bjr.20150171. Epub 2015 Aug 7. Review.

30.

Acetylcholine Protects against Candida albicans Infection by Inhibiting Biofilm Formation and Promoting Hemocyte Function in a Galleria mellonella Infection Model.

Rajendran R, Borghi E, Falleni M, Perdoni F, Tosi D, Lappin DF, O'Donnell L, Greetham D, Ramage G, Nile C.

Eukaryot Cell. 2015 Aug;14(8):834-44. doi: 10.1128/EC.00067-15. Epub 2015 Jun 19.

31.

Methicillin-Resistant Staphylococcus aureus in Raw Milk: Prevalence, SCCmec Typing, Enterotoxin Characterization, and Antimicrobial Resistance Patterns.

Riva A, Borghi E, Cirasola D, Colmegna S, Borgo F, Amato E, Pontello MM, Morace G.

J Food Prot. 2015 Jun;78(6):1142-6. doi: 10.4315/0362-028X.JFP-14-531.

32.

The Global Nutrition Report 2014: actions and accountability to accelerate the world's progress on nutrition.

Haddad L, Achadi E, Bendech MA, Ahuja A, Bhatia K, Bhutta Z, Blössner M, Borghi E, Colecraft E, de Onis M, Eriksen K, Fanzo J, Flores-Ayala R, Fracassi P, Kimani-Murage E, Nago Koukoubou E, Krasevec J, Newby H, Nugent R, Oenema S, Martin-Prével Y, Randel J, Requejo J, Shyam T, Udomkesmalee E, Reddy KS.

J Nutr. 2015 Apr;145(4):663-71. doi: 10.3945/jn.114.206078. Epub 2015 Mar 4.

33.

Efficacy of non-invasive mechanical ventilation in the general ward in patients with chronic obstructive pulmonary disease admitted for hypercapnic acute respiratory failure and pH < 7.35: a feasibility pilot study.

Fiorino S, Bacchi-Reggiani L, Detotto E, Battilana M, Borghi E, Denitto C, Dickmans C, Facchini B, Moretti R, Parini S, Testi M, Zamboni A, Cuppini A, Pisani L, Nava S.

Intern Med J. 2015 May;45(5):527-37. doi: 10.1111/imj.12726.

PMID:
25684643
34.

Antifungal drug resistance in Candida species.

Morace G, Perdoni F, Borghi E.

J Glob Antimicrob Resist. 2014 Dec;2(4):254-259. doi: 10.1016/j.jgar.2014.09.002. Epub 2014 Sep 28. Review.

PMID:
27873684
35.

A histological procedure to study fungal infection in the wax moth Galleria mellonella.

Perdoni F, Falleni M, Tosi D, Cirasola D, Romagnoli S, Braidotti P, Clementi E, Bulfamante G, Borghi E.

Eur J Histochem. 2014 Sep 23;58(3):2428. doi: 10.4081/ejh.2014.2428.

36.

Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity.

Sherry L, Rajendran R, Lappin DF, Borghi E, Perdoni F, Falleni M, Tosi D, Smith K, Williams C, Jones B, Nile CJ, Ramage G.

BMC Microbiol. 2014 Jul 5;14:182. doi: 10.1186/1471-2180-14-182.

37.

Hafnium oxide nanoparticles: toward an in vitro predictive biological effect?

Marill J, Anesary NM, Zhang P, Vivet S, Borghi E, Levy L, Pottier A.

Radiat Oncol. 2014 Jun 30;9:150. doi: 10.1186/1748-717X-9-150.

38.

Reliability and validity of the Italian version of the Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V).

Mozzanica F, Ginocchio D, Borghi E, Bachmann C, Schindler A.

Folia Phoniatr Logop. 2013;65(5):257-65. doi: 10.1159/000356479. Epub 2014 Apr 1.

PMID:
24714558
39.

Impact of Candida albicans hyphal wall protein 1 (HWP1) genotype on biofilm production and fungal susceptibility to microglial cells.

Orsi CF, Borghi E, Colombari B, Neglia RG, Quaglino D, Ardizzoni A, Morace G, Blasi E.

Microb Pathog. 2014 Apr-May;69-70:20-7. doi: 10.1016/j.micpath.2014.03.003. Epub 2014 Mar 28.

PMID:
24685698
40.

Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013.

Montagna MT, Lovero G, Borghi E, Amato G, Andreoni S, Campion L, Lo Cascio G, Lombardi G, Luzzaro F, Manso E, Mussap M, Pecile P, Perin S, Tangorra E, Tronci M, Iatta R, Morace G.

Eur Rev Med Pharmacol Sci. 2014;18(5):661-74. Review.

41.

Correlation between Candida albicans biofilm formation and invasion of the invertebrate host Galleria mellonella.

Borghi E, Romagnoli S, Fuchs BB, Cirasola D, Perdoni F, Tosi D, Braidotti P, Bulfamante G, Morace G, Mylonakis E.

Future Microbiol. 2014;9(2):163-73. doi: 10.2217/fmb.13.159.

PMID:
24571071
42.

New use of metals as nanosized radioenhancers.

Pottier A, Borghi E, Levy L.

Anticancer Res. 2014 Jan;34(1):443-53. Review.

PMID:
24403500
43.

Parental height and child growth from birth to 2 years in the WHO Multicentre Growth Reference Study.

Garza C, Borghi E, Onyango AW, de Onis M; WHO Multicentre Growth Reference Study Group.

Matern Child Nutr. 2013 Sep;9 Suppl 2:58-68. doi: 10.1111/mcn.12085.

PMID:
24074318
44.

The World Health Organization's global target for reducing childhood stunting by 2025: rationale and proposed actions.

de Onis M, Dewey KG, Borghi E, Onyango AW, Blössner M, Daelmans B, Piwoz E, Branca F.

Matern Child Nutr. 2013 Sep;9 Suppl 2:6-26. doi: 10.1111/mcn.12075.

PMID:
24074315
45.

Antifungal resistance does not necessarily affect Candida glabrata fitness.

Borghi E, Andreoni S, Cirasola D, Ricucci V, Sciota R, Morace G.

J Chemother. 2014 Feb;26(1):32-6. doi: 10.1179/1973947813Y.0000000100. Epub 2013 Dec 6.

PMID:
24091025
46.

Complementary feeding and attained linear growth among 6-23-month-old children.

Onyango AW, Borghi E, de Onis M, Casanovas Mdel C, Garza C.

Public Health Nutr. 2014 Sep;17(9):1975-83. doi: 10.1017/S1368980013002401. Epub 2013 Sep 19.

PMID:
24050753
47.

Experimental biofilm-related Candida infections.

Cirasola D, Sciota R, Vizzini L, Ricucci V, Morace G, Borghi E.

Future Microbiol. 2013 Jun;8(6):799-805. doi: 10.2217/fmb.13.36.

PMID:
23701334
48.

Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus.

Furi L, Ciusa ML, Knight D, Di Lorenzo V, Tocci N, Cirasola D, Aragones L, Coelho JR, Freitas AT, Marchi E, Moce L, Visa P, Northwood JB, Viti C, Borghi E, Orefici G; BIOHYPO Consortium, Morrissey I, Oggioni MR.

Antimicrob Agents Chemother. 2013 Aug;57(8):3488-97. doi: 10.1128/AAC.00498-13. Epub 2013 May 13.

49.

Lack of evidence for reduced fitness of clinical Staphylococcus aureus isolates with reduced susceptibility to triclosan.

Oggioni MR, Ciusa ML, Furi L, Baldassarri L, Orefici G, Cirasola D, Martinez JL, Morrissey I, Borghi E.

Antimicrob Agents Chemother. 2012 Nov;56(11):6068-9; author reply 6072. doi: 10.1128/AAC.01055-12. No abstract available.

50.

Nanoscale radiotherapy with hafnium oxide nanoparticles.

Maggiorella L, Barouch G, Devaux C, Pottier A, Deutsch E, Bourhis J, Borghi E, Levy L.

Future Oncol. 2012 Sep;8(9):1167-81. doi: 10.2217/fon.12.96.

PMID:
23030491

Supplemental Content

Loading ...
Support Center